A Phase Ib Trial of Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma

Project: Research project

Project Details

Description

A Phase Ib Trial of Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
StatusActive
Effective start/end date5/1/185/31/22

Funding

  • Cleveland Clinic

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.